A prospective study to validate the efficacy on the induction, consolidation, and maintenance therapy for the elderly multiple myeloma patients.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Lenalidomide; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 02 Jul 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 Jun 2013 New trial record